Literature DB >> 33121258

Socioeconomic status and colorectal cancer screening behaviors in a vulnerable multiethnic population.

Eduardo J Santiago-Rodríguez1, Natalie A Rivadeneira2, Jacqueline M Torres1, Urmimala Sarkar2, Robert A Hiatt1,3.   

Abstract

OBJECTIVE: Despite some progress in recent years, colorectal cancer (CRC) screening adherence in the United States is still suboptimal, particularly among disadvantaged groups. In this study, we assessed the association between socioeconomic status (SES) and self-reported screening non-adherence (SNA) in a sample of racial/ethnic minorities living in San Francisco, California. DESIGN/
METHODS: A total of 376 participants of the San Francisco version of the Health Information National Trends Survey (SF-HINTS) with ages 50-75 years were included in this cross-sectional study. SNA was defined as not reporting blood stool test within the past year and not reporting sigmoidoscopy/colonoscopy within the past 10 years. Poisson regression models with robust variance estimators were used to evaluate the relation of SES with SNA, adjusting for measured confounders. Results are reported as prevalence ratios (PR) and 95% confidence intervals (95% CI).
RESULTS: Overall SNA was 40%. In multivariable models including all respondents, retired participants had significantly lower SNA prevalence than employed participants (PR = 0.46, 95% CI = 0.26 0.83). In stratified analyses by race/ethnicity, Black respondents with less than high school (PR = 1.93, 95% CI = 1.09, 3.43) and those with high school or equivalent (PR = 1.88, 95% CI = 1.16, 3.04) had significantly higher SNA prevalence than those with at least some college. Among non-Hispanic Asian/Pacific Islanders, those disabled had significantly higher prevalence of SNA as compared to employed people (PR = 4.26, 95% CI = 2.11, 8.60). None of the SES indicators were significantly associated to SNA among Hispanics.
CONCLUSIONS: Participants with lower SES characteristics were less likely to adhere to CRC screening guidelines and being retired was a predictor of compliance. There was evidence of heterogeneity in associations between SES and CRC screening by race/ethnicity. Life circumstances of retired people could provide insights for designing interventions aimed to improve CRC screening uptake in these priority groups. Future efforts should consider mechanisms underlying differences by race/ethnicity.

Entities:  

Keywords:  San Francisco; Socioeconomic status; colorectal cancer; non-adherence; racial/ethnic minorities; screening

Mesh:

Year:  2020        PMID: 33121258      PMCID: PMC8081754          DOI: 10.1080/13557858.2020.1838454

Source DB:  PubMed          Journal:  Ethn Health        ISSN: 1355-7858            Impact factor:   2.732


  36 in total

1.  Factors Associated with Compliance of Blood Stool Test and Use of Colonoscopy in Underserved Communities of North Miami-Dade County, Florida.

Authors:  Meredith Leigh Wilcox; Juan Manuel Acuña; Pura Rodriguez de la Vega; Grettel Castro; Purnima Madhivanan
Journal:  J Health Care Poor Underserved       Date:  2015-11

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Accuracy of self-reported cancer-screening histories: a meta-analysis.

Authors:  Garth H Rauscher; Timothy P Johnson; Young Ik Cho; Jennifer A Walk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

Review 4.  Current Prevalence of Major Cancer Risk Factors and Screening Test Use in the United States: Disparities by Education and Race/Ethnicity.

Authors:  Ann Goding Sauer; Rebecca L Siegel; Ahmedin Jemal; Stacey A Fedewa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-04       Impact factor: 4.254

Review 5.  Effectiveness of Patient Navigation to Increase Cancer Screening in Populations Adversely Affected by Health Disparities: a Meta-analysis.

Authors:  Heidi D Nelson; Amy Cantor; Jesse Wagner; Rebecca Jungbauer; Rongwei Fu; Karli Kondo; Lucy Stillman; Ana Quiñones
Journal:  J Gen Intern Med       Date:  2020-07-22       Impact factor: 5.128

6.  Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey.

Authors:  Daudet Ilunga Tshiswaka; Tiffany Donley; Anthony Okafor; Peter Memiah; Justice Mbizo
Journal:  J Community Health       Date:  2017-06

7.  Health Information-seeking Behaviors and Preferences of a Diverse, Multilingual Urban Cohort.

Authors:  Elaine C Khoong; Gem M Le; Mekhala Hoskote; Natalie A Rivadeneira; Robert A Hiatt; Urmimala Sarkar
Journal:  Med Care       Date:  2019-06       Impact factor: 2.983

8.  Multiple imputation using chained equations: Issues and guidance for practice.

Authors:  Ian R White; Patrick Royston; Angela M Wood
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

9.  Low health literacy and cancer screening among Chinese Americans in California: a cross-sectional analysis.

Authors:  Tetine L Sentell; Janice Y Tsoh; Terry Davis; James Davis; Kathryn L Braun
Journal:  BMJ Open       Date:  2015-01-05       Impact factor: 2.692

10.  Socioeconomic and Racial/Ethnic Disparities in Cancer Mortality, Incidence, and Survival in the United States, 1950-2014: Over Six Decades of Changing Patterns and Widening Inequalities.

Authors:  Gopal K Singh; Ahmedin Jemal
Journal:  J Environ Public Health       Date:  2017-03-20
View more
  1 in total

Review 1.  From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center.

Authors:  Robert A Hiatt; Amanda Sibley; Brinda Venkatesh; Joyce Cheng; Niharika Dixit; Rena Fox; Pamela Ling; Tung Nguyen; Debora Oh; Nynikka R Palmer; Rena J Pasick; Michael B Potter; Ma Somsouk; Roberto Ariel Vargas; Maya Vijayaraghavan; Alan Ashworth
Journal:  Curr Epidemiol Rep       Date:  2022-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.